Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Dendreon receives FDA premarket approval for stem cell separation device

Aug. 13, 1999

Cambridge Combinatorial, Yamanouchi expand long-term relationship with new deal

Aug. 13, 1999

Third-generation lentiviral vectors from Cell Genesys boast improved safety features

Aug. 11, 1999

GeneTrace and Berlex collaborate on oncology research

Aug. 9, 1999

OSI Pharmaceuticals acquires certain Cadus drug discovery programs

Aug. 9, 1999

CytoTherapeutics reports on new technology for expanding stem/progenitor cell lines

Aug. 9, 1999

Atugen and Roche Bioscience enter target validation collaboration

Aug. 5, 1999

Cell Therapeutics discloses CT-2412 and related compounds for increasing drug bioavailability

Aug. 4, 1999

Lexicon Genetics signs knockout mouse agreement with Millennium

Aug. 4, 1999

OSI grants nonexclusive license for gene transcription patents to Pharmacia & Upjohn

Aug. 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...